genome
The Pan-Cancer project
EMBL co-leads most comprehensive study of genetic causes of cancer…
Protecting data in the cloud
Cloud computing offers unprecedented opportunities for global-scale research collaborations. It also presents a unique set of challenges in terms of data protection and the ethics of data sharing.…
Characterising RNA alterations in cancer
The largest and most comprehensive catalogue of cancer-specific RNA alterations reveals new insights into the cancer genome.…
Cancer mutations occur decades before diagnosis
Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Francis Crick Institute have analysed the whole genomes of over 2600 tumours from 38 different cancer types to determine the chronology of genomic changes during cancer development.…
Studying DNA rearrangement to understand cancer
Using the dataset from the Pan-Cancer project, scientists has developed methods to group, classify, and describe large rearrangements of the genome that are a key driver of cancer.…
Scientists identify new genetic drivers of cancer
Analysis of whole cancer genomes gives key insights into the role of the non-coding genome in cancer…
Chromothripsis in human cancer
Researchers at Harvard Medical School and EMBL-EBI have carried out the largest analysis across cancer types of the newly discovered mutational phenomenon chromothripsis.…
Finding genetic cancer risks
Using the data from the Pan-Cancer project EMBL scientists describe how our genetic background influences cancer development.…
Editing the ethical code
Professor Tim Lewens challenges the human genome’s unique place in bioethics…
Catalogue of structural variants
Thorough characterisation of structural variants in human genomes…
